English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 100 | Tables: 95 | Pharma & Healthcare
The global market for Topical Antibiotic Drug was valued at US$ 10242 million in the year 2024 and is projected to reach a revised size of US$ 12976 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Topical antibiotic drugs refer to anti-infective medications applied directly to the skin or mucosal surfaces in the form of creams, ointments, sprays, powders, gels, or patches, primarily used for the prevention and treatment of bacterial skin and soft tissue infections such as abrasions, burns, surgical incisions, pustules, and folliculitis. Compared with oral or injectable antibiotics, topical antibiotics provide high local drug concentrations, minimize systemic side effects, and reduce the risk of resistance. In recent years, their applications have expanded in chronic wound management, daily skincare, and animal health, drawing significant attention from hospitals, pharmacies, and the OTC retail market. With stricter antibiotic regulations, the promotion of rational antimicrobial use, and the rise of self-medication awareness among patients, topical antibiotics are emerging as a key focus area for pharmaceutical companies, healthcare providers, and investors.
With the rising prevalence of skin diseases and the growing population of patients with chronic conditions such as diabetes and aging, the demand for topical antibiotic drugs is steadily increasing. Annual reports and brokerage research indicate a stronger demand for safe, effective, and convenient local antimicrobial solutions. Government initiatives to strengthen hospital infection control policies are further driving adoption in clinical settings. Additionally, the development of innovative formulations such as nanocarriers and transdermal delivery systems enhances market attractiveness and creates opportunities for differentiation.
Despite strong growth potential, the topical antibiotic drug market faces risks related to antibiotic resistance, stringent regulatory frameworks, and product homogeneity. In certain countries, specific ingredients have been restricted, requiring companies to provide more robust clinical evidence on safety and long-term efficacy. Meanwhile, the OTC segment is highly competitive, with low-cost generics flooding the market, intensifying pricing and distribution challenges for original and innovative brands.
Hospitals and pharmacies remain the core sales channels for topical antibiotics, while consumer self-medication and household demand are fueling rapid growth in retail and e-commerce channels. Strong demand in wound care, postoperative recovery, and pediatric skin infections is driving expansion into diverse formulations and combination products. Moreover, the growing importance of pet health and livestock management is creating new demand in veterinary applications.
The upstream segment mainly relies on active pharmaceutical ingredients (APIs) and excipient supplies. Key APIs such as erythromycin, clindamycin, and mupirocin are subject to environmental regulations and production technology upgrades, making supply stability a priority. On the excipient side, innovations in cream bases, sustained-release materials, and skin penetration enhancers not only improve drug stability but also support formulation innovation. Overall, upstream technological advancement and compliance trends provide long-term support for the topical antibiotic drug industry chain.
This report aims to provide a comprehensive presentation of the global market for Topical Antibiotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Antibiotic Drug.
The Topical Antibiotic Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Topical Antibiotic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, by Drug and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Antibiotic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Merck & Co
Sandoz
Sumitomo Pharma
Fresenius
AbbVie
Hailin Pharmaceuticals
Bausch Health
Southwest Pharmaceuticals
Zhuhai United Pharmaceuticals
Qilu Pharmaceuticals
China Resources Sanjiu Pharmaceuticals
Shenzhen Xinlitai Pharmaceuticals
Shanghai Modern Pharmaceuticals
North China Pharmaceuticals
Sun Pharmaceuticals
Hikma Pharmaceuticals
Shijiazhuang Pharmaceutical Group
Resun Pharmaceuticals
Segment by Type
Creams
Ointments
Sprays
Other
Segment by Drug
β-lactams
Tetracyclines
Macrolides
Aminoglycosides
Peptides
Quinolones
Other
Segment by Application
Hospitals
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Drug etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Antibiotic Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Topical Antibiotic Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Creams
1.2.3 Ointments
1.2.4 Sprays
1.2.5 Other
1.3 Market by Drug
1.3.1 Global Topical Antibiotic Drug Market Size Growth Rate by Drug: 2020 VS 2024 VS 2031
1.3.2 β-lactams
1.3.3 Tetracyclines
1.3.4 Macrolides
1.3.5 Aminoglycosides
1.3.6 Peptides
1.3.7 Quinolones
1.3.8 Other
1.4 Market by Application
1.4.1 Global Topical Antibiotic Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.4.2 Hospitals
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Topical Antibiotic Drug Market Perspective (2020-2031)
2.2 Global Topical Antibiotic Drug Growth Trends by Region
2.2.1 Global Topical Antibiotic Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Topical Antibiotic Drug Historic Market Size by Region (2020-2025)
2.2.3 Topical Antibiotic Drug Forecasted Market Size by Region (2026-2031)
2.3 Topical Antibiotic Drug Market Dynamics
2.3.1 Topical Antibiotic Drug Industry Trends
2.3.2 Topical Antibiotic Drug Market Drivers
2.3.3 Topical Antibiotic Drug Market Challenges
2.3.4 Topical Antibiotic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Topical Antibiotic Drug Players by Revenue
3.1.1 Global Top Topical Antibiotic Drug Players by Revenue (2020-2025)
3.1.2 Global Topical Antibiotic Drug Revenue Market Share by Players (2020-2025)
3.2 Global Top Topical Antibiotic Drug Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Topical Antibiotic Drug Revenue
3.4 Global Topical Antibiotic Drug Market Concentration Ratio
3.4.1 Global Topical Antibiotic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Topical Antibiotic Drug Revenue in 2024
3.5 Global Key Players of Topical Antibiotic Drug Head office and Area Served
3.6 Global Key Players of Topical Antibiotic Drug, Product and Application
3.7 Global Key Players of Topical Antibiotic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Topical Antibiotic Drug Breakdown Data by Type
4.1 Global Topical Antibiotic Drug Historic Market Size by Type (2020-2025)
4.2 Global Topical Antibiotic Drug Forecasted Market Size by Type (2026-2031)
5 Topical Antibiotic Drug Breakdown Data by Application
5.1 Global Topical Antibiotic Drug Historic Market Size by Application (2020-2025)
5.2 Global Topical Antibiotic Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Topical Antibiotic Drug Market Size (2020-2031)
6.2 North America Topical Antibiotic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Topical Antibiotic Drug Market Size by Country (2020-2025)
6.4 North America Topical Antibiotic Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Topical Antibiotic Drug Market Size (2020-2031)
7.2 Europe Topical Antibiotic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Topical Antibiotic Drug Market Size by Country (2020-2025)
7.4 Europe Topical Antibiotic Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Topical Antibiotic Drug Market Size (2020-2031)
8.2 Asia-Pacific Topical Antibiotic Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Topical Antibiotic Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Topical Antibiotic Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Topical Antibiotic Drug Market Size (2020-2031)
9.2 Latin America Topical Antibiotic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Topical Antibiotic Drug Market Size by Country (2020-2025)
9.4 Latin America Topical Antibiotic Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Topical Antibiotic Drug Market Size (2020-2031)
10.2 Middle East & Africa Topical Antibiotic Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Topical Antibiotic Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Topical Antibiotic Drug Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Topical Antibiotic Drug Introduction
11.1.4 GSK Revenue in Topical Antibiotic Drug Business (2020-2025)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Topical Antibiotic Drug Introduction
11.2.4 Pfizer Revenue in Topical Antibiotic Drug Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Topical Antibiotic Drug Introduction
11.3.4 Merck & Co Revenue in Topical Antibiotic Drug Business (2020-2025)
11.3.5 Merck & Co Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Topical Antibiotic Drug Introduction
11.4.4 Sandoz Revenue in Topical Antibiotic Drug Business (2020-2025)
11.4.5 Sandoz Recent Development
11.5 Sumitomo Pharma
11.5.1 Sumitomo Pharma Company Details
11.5.2 Sumitomo Pharma Business Overview
11.5.3 Sumitomo Pharma Topical Antibiotic Drug Introduction
11.5.4 Sumitomo Pharma Revenue in Topical Antibiotic Drug Business (2020-2025)
11.5.5 Sumitomo Pharma Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Details
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Topical Antibiotic Drug Introduction
11.6.4 Fresenius Revenue in Topical Antibiotic Drug Business (2020-2025)
11.6.5 Fresenius Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Topical Antibiotic Drug Introduction
11.7.4 AbbVie Revenue in Topical Antibiotic Drug Business (2020-2025)
11.7.5 AbbVie Recent Development
11.8 Hailin Pharmaceuticals
11.8.1 Hailin Pharmaceuticals Company Details
11.8.2 Hailin Pharmaceuticals Business Overview
11.8.3 Hailin Pharmaceuticals Topical Antibiotic Drug Introduction
11.8.4 Hailin Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.8.5 Hailin Pharmaceuticals Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Topical Antibiotic Drug Introduction
11.9.4 Bausch Health Revenue in Topical Antibiotic Drug Business (2020-2025)
11.9.5 Bausch Health Recent Development
11.10 Southwest Pharmaceuticals
11.10.1 Southwest Pharmaceuticals Company Details
11.10.2 Southwest Pharmaceuticals Business Overview
11.10.3 Southwest Pharmaceuticals Topical Antibiotic Drug Introduction
11.10.4 Southwest Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.10.5 Southwest Pharmaceuticals Recent Development
11.11 Zhuhai United Pharmaceuticals
11.11.1 Zhuhai United Pharmaceuticals Company Details
11.11.2 Zhuhai United Pharmaceuticals Business Overview
11.11.3 Zhuhai United Pharmaceuticals Topical Antibiotic Drug Introduction
11.11.4 Zhuhai United Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.11.5 Zhuhai United Pharmaceuticals Recent Development
11.12 Qilu Pharmaceuticals
11.12.1 Qilu Pharmaceuticals Company Details
11.12.2 Qilu Pharmaceuticals Business Overview
11.12.3 Qilu Pharmaceuticals Topical Antibiotic Drug Introduction
11.12.4 Qilu Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.12.5 Qilu Pharmaceuticals Recent Development
11.13 China Resources Sanjiu Pharmaceuticals
11.13.1 China Resources Sanjiu Pharmaceuticals Company Details
11.13.2 China Resources Sanjiu Pharmaceuticals Business Overview
11.13.3 China Resources Sanjiu Pharmaceuticals Topical Antibiotic Drug Introduction
11.13.4 China Resources Sanjiu Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.13.5 China Resources Sanjiu Pharmaceuticals Recent Development
11.14 Shenzhen Xinlitai Pharmaceuticals
11.14.1 Shenzhen Xinlitai Pharmaceuticals Company Details
11.14.2 Shenzhen Xinlitai Pharmaceuticals Business Overview
11.14.3 Shenzhen Xinlitai Pharmaceuticals Topical Antibiotic Drug Introduction
11.14.4 Shenzhen Xinlitai Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.14.5 Shenzhen Xinlitai Pharmaceuticals Recent Development
11.15 Shanghai Modern Pharmaceuticals
11.15.1 Shanghai Modern Pharmaceuticals Company Details
11.15.2 Shanghai Modern Pharmaceuticals Business Overview
11.15.3 Shanghai Modern Pharmaceuticals Topical Antibiotic Drug Introduction
11.15.4 Shanghai Modern Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.15.5 Shanghai Modern Pharmaceuticals Recent Development
11.16 North China Pharmaceuticals
11.16.1 North China Pharmaceuticals Company Details
11.16.2 North China Pharmaceuticals Business Overview
11.16.3 North China Pharmaceuticals Topical Antibiotic Drug Introduction
11.16.4 North China Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.16.5 North China Pharmaceuticals Recent Development
11.17 Sun Pharmaceuticals
11.17.1 Sun Pharmaceuticals Company Details
11.17.2 Sun Pharmaceuticals Business Overview
11.17.3 Sun Pharmaceuticals Topical Antibiotic Drug Introduction
11.17.4 Sun Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.17.5 Sun Pharmaceuticals Recent Development
11.18 Hikma Pharmaceuticals
11.18.1 Hikma Pharmaceuticals Company Details
11.18.2 Hikma Pharmaceuticals Business Overview
11.18.3 Hikma Pharmaceuticals Topical Antibiotic Drug Introduction
11.18.4 Hikma Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.18.5 Hikma Pharmaceuticals Recent Development
11.19 Shijiazhuang Pharmaceutical Group
11.19.1 Shijiazhuang Pharmaceutical Group Company Details
11.19.2 Shijiazhuang Pharmaceutical Group Business Overview
11.19.3 Shijiazhuang Pharmaceutical Group Topical Antibiotic Drug Introduction
11.19.4 Shijiazhuang Pharmaceutical Group Revenue in Topical Antibiotic Drug Business (2020-2025)
11.19.5 Shijiazhuang Pharmaceutical Group Recent Development
11.20 Resun Pharmaceuticals
11.20.1 Resun Pharmaceuticals Company Details
11.20.2 Resun Pharmaceuticals Business Overview
11.20.3 Resun Pharmaceuticals Topical Antibiotic Drug Introduction
11.20.4 Resun Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025)
11.20.5 Resun Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Topical Antibiotic Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Creams
Table 3. Key Players of Ointments
Table 4. Key Players of Sprays
Table 5. Key Players of Other
Table 6. Global Topical Antibiotic Drug Market Size Growth Rate by Drug (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of β-lactams
Table 8. Key Players of Tetracyclines
Table 9. Key Players of Macrolides
Table 10. Key Players of Aminoglycosides
Table 11. Key Players of Peptides
Table 12. Key Players of Quinolones
Table 13. Key Players of Other
Table 14. Global Topical Antibiotic Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Topical Antibiotic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Topical Antibiotic Drug Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Topical Antibiotic Drug Market Share by Region (2020-2025)
Table 18. Global Topical Antibiotic Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Topical Antibiotic Drug Market Share by Region (2026-2031)
Table 20. Topical Antibiotic Drug Market Trends
Table 21. Topical Antibiotic Drug Market Drivers
Table 22. Topical Antibiotic Drug Market Challenges
Table 23. Topical Antibiotic Drug Market Restraints
Table 24. Global Topical Antibiotic Drug Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Topical Antibiotic Drug Market Share by Players (2020-2025)
Table 26. Global Top Topical Antibiotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Antibiotic Drug as of 2024)
Table 27. Ranking of Global Top Topical Antibiotic Drug Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Topical Antibiotic Drug Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Topical Antibiotic Drug, Headquarters and Area Served
Table 30. Global Key Players of Topical Antibiotic Drug, Product and Application
Table 31. Global Key Players of Topical Antibiotic Drug, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Topical Antibiotic Drug Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Topical Antibiotic Drug Revenue Market Share by Type (2020-2025)
Table 35. Global Topical Antibiotic Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Topical Antibiotic Drug Revenue Market Share by Type (2026-2031)
Table 37. Global Topical Antibiotic Drug Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Topical Antibiotic Drug Revenue Market Share by Application (2020-2025)
Table 39. Global Topical Antibiotic Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Topical Antibiotic Drug Revenue Market Share by Application (2026-2031)
Table 41. North America Topical Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Topical Antibiotic Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Topical Antibiotic Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Topical Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Topical Antibiotic Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Topical Antibiotic Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Topical Antibiotic Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Topical Antibiotic Drug Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Topical Antibiotic Drug Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Topical Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Topical Antibiotic Drug Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Topical Antibiotic Drug Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Topical Antibiotic Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Topical Antibiotic Drug Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Topical Antibiotic Drug Market Size by Country (2026-2031) & (US$ Million)
Table 56. GSK Company Details
Table 57. GSK Business Overview
Table 58. GSK Topical Antibiotic Drug Product
Table 59. GSK Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 60. GSK Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Topical Antibiotic Drug Product
Table 64. Pfizer Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Merck & Co Company Details
Table 67. Merck & Co Business Overview
Table 68. Merck & Co Topical Antibiotic Drug Product
Table 69. Merck & Co Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 70. Merck & Co Recent Development
Table 71. Sandoz Company Details
Table 72. Sandoz Business Overview
Table 73. Sandoz Topical Antibiotic Drug Product
Table 74. Sandoz Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 75. Sandoz Recent Development
Table 76. Sumitomo Pharma Company Details
Table 77. Sumitomo Pharma Business Overview
Table 78. Sumitomo Pharma Topical Antibiotic Drug Product
Table 79. Sumitomo Pharma Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 80. Sumitomo Pharma Recent Development
Table 81. Fresenius Company Details
Table 82. Fresenius Business Overview
Table 83. Fresenius Topical Antibiotic Drug Product
Table 84. Fresenius Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 85. Fresenius Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Topical Antibiotic Drug Product
Table 89. AbbVie Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Hailin Pharmaceuticals Company Details
Table 92. Hailin Pharmaceuticals Business Overview
Table 93. Hailin Pharmaceuticals Topical Antibiotic Drug Product
Table 94. Hailin Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 95. Hailin Pharmaceuticals Recent Development
Table 96. Bausch Health Company Details
Table 97. Bausch Health Business Overview
Table 98. Bausch Health Topical Antibiotic Drug Product
Table 99. Bausch Health Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 100. Bausch Health Recent Development
Table 101. Southwest Pharmaceuticals Company Details
Table 102. Southwest Pharmaceuticals Business Overview
Table 103. Southwest Pharmaceuticals Topical Antibiotic Drug Product
Table 104. Southwest Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 105. Southwest Pharmaceuticals Recent Development
Table 106. Zhuhai United Pharmaceuticals Company Details
Table 107. Zhuhai United Pharmaceuticals Business Overview
Table 108. Zhuhai United Pharmaceuticals Topical Antibiotic Drug Product
Table 109. Zhuhai United Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 110. Zhuhai United Pharmaceuticals Recent Development
Table 111. Qilu Pharmaceuticals Company Details
Table 112. Qilu Pharmaceuticals Business Overview
Table 113. Qilu Pharmaceuticals Topical Antibiotic Drug Product
Table 114. Qilu Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 115. Qilu Pharmaceuticals Recent Development
Table 116. China Resources Sanjiu Pharmaceuticals Company Details
Table 117. China Resources Sanjiu Pharmaceuticals Business Overview
Table 118. China Resources Sanjiu Pharmaceuticals Topical Antibiotic Drug Product
Table 119. China Resources Sanjiu Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 120. China Resources Sanjiu Pharmaceuticals Recent Development
Table 121. Shenzhen Xinlitai Pharmaceuticals Company Details
Table 122. Shenzhen Xinlitai Pharmaceuticals Business Overview
Table 123. Shenzhen Xinlitai Pharmaceuticals Topical Antibiotic Drug Product
Table 124. Shenzhen Xinlitai Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 125. Shenzhen Xinlitai Pharmaceuticals Recent Development
Table 126. Shanghai Modern Pharmaceuticals Company Details
Table 127. Shanghai Modern Pharmaceuticals Business Overview
Table 128. Shanghai Modern Pharmaceuticals Topical Antibiotic Drug Product
Table 129. Shanghai Modern Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 130. Shanghai Modern Pharmaceuticals Recent Development
Table 131. North China Pharmaceuticals Company Details
Table 132. North China Pharmaceuticals Business Overview
Table 133. North China Pharmaceuticals Topical Antibiotic Drug Product
Table 134. North China Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 135. North China Pharmaceuticals Recent Development
Table 136. Sun Pharmaceuticals Company Details
Table 137. Sun Pharmaceuticals Business Overview
Table 138. Sun Pharmaceuticals Topical Antibiotic Drug Product
Table 139. Sun Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 140. Sun Pharmaceuticals Recent Development
Table 141. Hikma Pharmaceuticals Company Details
Table 142. Hikma Pharmaceuticals Business Overview
Table 143. Hikma Pharmaceuticals Topical Antibiotic Drug Product
Table 144. Hikma Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 145. Hikma Pharmaceuticals Recent Development
Table 146. Shijiazhuang Pharmaceutical Group Company Details
Table 147. Shijiazhuang Pharmaceutical Group Business Overview
Table 148. Shijiazhuang Pharmaceutical Group Topical Antibiotic Drug Product
Table 149. Shijiazhuang Pharmaceutical Group Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 150. Shijiazhuang Pharmaceutical Group Recent Development
Table 151. Resun Pharmaceuticals Company Details
Table 152. Resun Pharmaceuticals Business Overview
Table 153. Resun Pharmaceuticals Topical Antibiotic Drug Product
Table 154. Resun Pharmaceuticals Revenue in Topical Antibiotic Drug Business (2020-2025) & (US$ Million)
Table 155. Resun Pharmaceuticals Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
Table 159. Authors List of This Report
List of Figures
Figure 1. Topical Antibiotic Drug Picture
Figure 2. Global Topical Antibiotic Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Topical Antibiotic Drug Market Share by Type: 2024 VS 2031
Figure 4. Creams Features
Figure 5. Ointments Features
Figure 6. Sprays Features
Figure 7. Other Features
Figure 8. Global Topical Antibiotic Drug Market Size Comparison by Drug (2020-2031) & (US$ Million)
Figure 9. β-lactams Features
Figure 10. Tetracyclines Features
Figure 11. Macrolides Features
Figure 12. Aminoglycosides Features
Figure 13. Peptides Features
Figure 14. Quinolones Features
Figure 15. Other Features
Figure 16. Global Topical Antibiotic Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Topical Antibiotic Drug Market Share by Application: 2024 VS 2031
Figure 18. Hospitals Case Studies
Figure 19. Retail Pharmacy Case Studies
Figure 20. Other Case Studies
Figure 21. Topical Antibiotic Drug Report Years Considered
Figure 22. Global Topical Antibiotic Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 23. Global Topical Antibiotic Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Topical Antibiotic Drug Market Share by Region: 2024 VS 2031
Figure 25. Global Topical Antibiotic Drug Market Share by Players in 2024
Figure 26. Global Topical Antibiotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Topical Antibiotic Drug Revenue in 2024
Figure 28. North America Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. North America Topical Antibiotic Drug Market Share by Country (2020-2031)
Figure 30. United States Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Canada Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Topical Antibiotic Drug Market Share by Country (2020-2031)
Figure 34. Germany Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. France Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. U.K. Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Italy Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Ireland Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Topical Antibiotic Drug Market Share by Region (2020-2031)
Figure 42. China Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Japan Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Australia & New Zealand Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Topical Antibiotic Drug Market Share by Country (2020-2031)
Figure 50. Mexico Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Brazil Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Topical Antibiotic Drug Market Share by Country (2020-2031)
Figure 54. Israel Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. UAE Topical Antibiotic Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. GSK Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 59. Merck & Co Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 60. Sandoz Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 61. Sumitomo Pharma Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 62. Fresenius Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 63. AbbVie Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 64. Hailin Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 65. Bausch Health Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 66. Southwest Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 67. Zhuhai United Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 68. Qilu Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 69. China Resources Sanjiu Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 70. Shenzhen Xinlitai Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 71. Shanghai Modern Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 72. North China Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 73. Sun Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 74. Hikma Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 75. Shijiazhuang Pharmaceutical Group Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 76. Resun Pharmaceuticals Revenue Growth Rate in Topical Antibiotic Drug Business (2020-2025)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
